Editorial: Microbiota homeostasis and metabolic reprogramming in cancer development and digestive diseases

Kai Li

Abstract

Linked entities

Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.

Genes5

PGK1 SLC5A5 PFKP PKM ATP8A2

Proteins5

Species3

Lactobacillus(genus)Bifidobacterium(genus)Homo sapiens(human · species)

Chemicals18

fatty acid lactate propofol lidocaine bile acids arginine lipid lipopolysaccharide glutamine TAN iodine ropivacaine thyroxine dexmedetomidine SCFA indole Glucose triiodothyronine

Diseases14

multidrug resistance Tumor inflammation digestive diseases gastric, colorectal, lung, breast, and head and neck squamous cell carcinomas gynecological malignancies colorectal liver metastasis cytotoxic colorectal cancer tumorigenesis hypoxic thyroid cancer autoimmune thyroid diseases gut dysbiosis

Peer Reviews

No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.

Videos

No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.

Taxonomy

TopicsDiet and metabolism studies · Nutrition, Genetics, and Disease · Gut microbiota and health